MUTATIONS IN THE CHANNEL DOMAIN ALTER DESENSITIZATION OF A NEURONAL NICOTINIC RECEPTOR

被引:463
|
作者
REVAH, F
BERTRAND, D
GALZI, JL
DEVILLERSTHIERY, A
MULLE, C
HUSSY, N
BERTRAND, S
BALLIVET, M
CHANGEUX, JP
机构
[1] UNIV GENEVA,DEPT BIOCHIM,CH-1211 GENEVA 4,SWITZERLAND
[2] UNIV GENEVA,MED CTR,FAC MED,DEPT PHYSIOL,CH-1211 GENEVA 4,SWITZERLAND
关键词
D O I
10.1038/353846a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A VARIETY of ligand-gated ion channels undergo a fast activation process after the rapid application of agonist and also a slower transition towards desensitized or inactivated closed channel states when exposure to agonist is prolonged 1-5. Desensitization involves at least two distinct closed states in the acetylcholine receptor, each with an affinity for agonists higher than those of the resting or active conformations 1-5. Here we investigate how structural elements could be involved in the desensitization of the acetylcholine-gated ion channel from the chick brain alpha-bungarotoxin sensitive homo-oligomeric alpha-7 receptor 6,7, using site-directed mutagenesis and expression in Xenopus oocytes. Mutations of the highly conserved leucine 247 residue 8,9 from the uncharged MII segment of alpha-7 suppress inhibition by the open-channel blocker QX-222 (ref. 10), indicating that this residue, like others from MII (refs 11-22), faces the lumen of the channel. But, unexpectedly, the same mutations decrease the rate of desensitization of the response, increase the apparent affinity for acetylcholine and abolish current rectification. Moreover, unlike wild-type alpha-7, which has channels with a single conductance level, the leucine-to-threonine mutant has an additional conducting state active at low acetylcholine concentrations. It is possible that mutation of Leu 247 renders conductive one of the high-affinity desensitized states of the receptor.
引用
收藏
页码:846 / 849
页数:4
相关论文
共 50 条
  • [41] Dimensions of neuronal nicotinic acetylcholine receptor channel as estimated from the analysis of the channel-blocking effects
    Kertser, S
    Bobryshev, A
    Voitenko, S
    Gmiro, V
    Brovtsyna, N
    Skok, V
    JOURNAL OF MEMBRANE BIOLOGY, 1998, 163 (02): : 111 - 118
  • [42] Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatment
    Ahamed, Ashif
    Samanta, Arijit
    Alam, Syed Sahajada Mahafujul
    Mir, Showkat Ahmad
    Jamil, Zarnain
    Ali, Safdar
    Hoque, Mehboob
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2024, 125 (02)
  • [43] Mutations in the S4 domain of a pacemaker channel alter its voltage dependence
    Vaca, L
    Stieber, J
    Zong, X
    Ludwig, A
    Hofmann, F
    Biel, M
    FEBS LETTERS, 2000, 479 (1-2) : 35 - 40
  • [44] Study the specificity of mutants forms of extracellular domain of α7 neuronal nicotinic acetylcholine receptor
    Ojomoko, L.
    Spirova, E.
    FEBS JOURNAL, 2014, 281 : 383 - 383
  • [45] Role of the extracellular transmembrane domain interface in gating and pharmacology of a heteromeric neuronal nicotinic receptor
    Aldea, Marcos
    Castillo, Mar
    Mulet, Jose
    Sala, Salvador
    Criado, Manuel
    Sala, Francisco
    JOURNAL OF NEUROCHEMISTRY, 2010, 113 (04) : 1036 - 1045
  • [46] Neuronal nicotinic ACh receptor modulators
    Holladay, MW
    DRUG DISCOVERY TODAY, 1998, 3 (05) : 240 - 241
  • [47] Neuronal nicotinic acetylcholine receptor and epilepsy
    Buisson, B
    Curtis, L
    Bertrand, D
    GENETICS OF FOCAL EPILEPSIES: CLINICAL ASPECTS AND MOLECULAR BIOLOGY, 1999, 13 : 187 - 202
  • [48] Neuronal nicotinic acetylcholine receptor ligands
    不详
    DRUG DISCOVERY TODAY, 1998, 3 (02) : 89 - 89
  • [49] Neuronal nicotinic acetylcholine receptor agonists
    McDonald, IA
    Vernier, JM
    Cosford, N
    CoreyNaeve, J
    CURRENT PHARMACEUTICAL DESIGN, 1996, 2 (04) : 357 - 366
  • [50] Neuronal nicotinic acetylcholine receptor agonists
    Toma, L
    Barlocco, D
    Gelain, A
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (07) : 1029 - 1040